Lord, Abbett & Co. LLC Amicus Therapeutics, Inc. Transaction History

Lord, Abbett & Co. LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$8.38 - $13.44 $12.1 Million - $19.4 Million	-1,440,999 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$11.6 - $16.54 $5,370 - $7,658	-463 Reduced 0.03%	1,440,999 $17.4 Million
Q2 2018 Aug 14, 2018	SELL	$13.13 - $17.09 $857,690 - $1.12 Million	-65,323 Reduced 4.34%	1,441,462 $22.5 Million
Q1 2018 May 15, 2018	BUY	$13.76 - $17.12 $20.7 Million - $25.8 Million	1,506,785 New	1,506,785 $22.7 Million

311

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.53B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Lord, Abbett & Co. LLC with notifications on news.